
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
52%
Total
Publications
1K
Total Open
Publications
526
Total
Citations
30K
Open Access
Percentage
52%
Total
Publications
1K
Total Open
Publications
526
Total
Citations
30K
Breakdown
Publisher Open
22%
Both
25%
Other Platform Open
4%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 38%
176
Hybrid 27%
125
No Guarantees 35%
166
Other Platform Open
Domain 69%
214
Institution 36%
113
Other Internet 20%
61
Preprint 7%
22
Public 2%
7
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 211 |
DOI | Other Internet | 58 |
Royal Netherlands Academy of Arts and Sciences | Institution | 22 |
Europe PMC | Domain | 16 |
University of Groningen | Institution | 13 |
epfl.ch OAI-PMH Repository | Institution | 12 |
arXiv | Preprint | 12 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |
Universitat Autònoma de Barcelona | Institution | 6 |
KU Leuven | Institution | 6 |